Verónica Galván

Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease

Patricia Spilman, Natalia Podlutskaya, Matthew J. Hart et al. · PLoS ONE · 2010 · 1K citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

Enhanced neurogenesis in Alzheimer's disease transgenic (PDGF-APP _Sw,Ind ) mice

Kunlin Jin, Verónica Galván, Lin Xie et al. · Proceedings of the National Academy of Sciences · 2004 · 434 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Herpes simplex virus 1 induces and blocks apoptosis at multiple steps during infection and protects cells from exogenous inducers in a cell-type-dependent manner

Verónica Galván, Bernard Roizman · Proceedings of the National Academy of Sciences · 1998 · 246 citations

Life Sciences, Cell Biology, Infectious Diseases +16

Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664

Verónica Galván, Olivia Gorostiza, Surita Banwait et al. · Proceedings of the National Academy of Sciences · 2006 · 233 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Chronic inhibition of mammalian target of rapamycin by rapamycin modulates cognitive and non-cognitive components of behavior throughout lifespan in mice

Jonathan J. Halloran, Stacy A. Hussong, Raquel R Burbank et al. · Neuroscience · 2012 · 221 citations

Medicine, Neuroscience, Pharmacology +13